NCT01312051

Brief Summary

Blacks are at increased risk for obesity, type 2 diabetes mellitus and cardiovascular disease. A common pathogenetic link among these entities is insulin resistance/hyperinsulinemia. The specific aims of this project are: 1) to compare skeletal muscle lipid content (SMLC) in black vs white children by computed tomography (CT) scan of the mid-thigh, and assess the relationship to in vivo insulin sensitivity; 2) to test the hypothesis that free fatty acid (FFA) - induced insulin resistance is associated with larger increases in intramyocellular lipid (IMCL) in black vs white adolescents; 3) to examine if β-cell insulin secretion in prepubertal black children is more sensitive to the stimulatory effect of FFA than in whites; and 4) to test if the β-cell in black obese adolescents is more susceptible to the lipotoxic effect of FFA compared with whites. The methods to be used are: the well- established CT method as well as Magnetic Resonance Spectroscopy (1H-MRS) to assess SMLC and IMCL; intralipid infusion to elevate circulating FFA levels; the hyperinsulinemic-euglycemic clamp with stable isotopes and indirect calorimetry to measure insulin sensitivity and substrate turnover; the hyperglycemic clamp to assess insulin secretion; DEXA and whole body MRI for body composition assessments.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
156

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2004

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2004

Completed
6.7 years until next milestone

First Submitted

Initial submission to the registry

March 9, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 10, 2011

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 20, 2011

Completed
Last Updated

October 18, 2017

Status Verified

October 1, 2017

Enrollment Period

7.2 years

First QC Date

March 9, 2011

Last Update Submit

October 16, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Skeletal muscle lipid content, insulin sensitivity and insulin secretion

    Assessments at 2 timepoints occur within a 2 to 3 week period

Study Arms (4)

Protocol 1

Healthy, overweight 11 to 17 year old black and white adolescents

Protocol 2

Healthy, normal-weight 11 to 17 year old black and white adolescents

Protocol 3

Healthy, normal-weight 8 to 12 year old black and white adolescents

Protocol 4

Healthy, overweight 11 to 17 year old black and white adolescents

Eligibility Criteria

Age8 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Healthy black and white volunteers who are 8 to 17 years of age

You may qualify if:

  • Protocols 1 \& 4:
  • Age 11-17 years
  • Male or Female
  • Healthy
  • Obese, BMI ≥ 95 percentile
  • Pubertal/Tanner Stage II-V
  • African American or White American, based on self identity with no admixture for 3 generations
  • Protocol 2:
  • Age 11-17 years
  • Male or Female
  • Healthy
  • Normal Weight, BMI 10- 95 percentile
  • Pubertal/Tanner Stage II-V
  • African American or White American, based on self-identity with no admixture for 3 generations
  • Protocol 3:
  • +6 more criteria

You may not qualify if:

  • Medications which interfere with metabolism
  • Hemocue \< 12 gm/dl in pubertal subjects and \<11gm/dl in prepubertal subjects
  • Positive serum pregnancy test
  • Recent significant weight change or dieting
  • Presence of disease (i.e.diabetes, hypothyroidism, genetic dyslipidemia, etc)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital of Pittsburgh of UPMC

Pittsburgh, Pennsylvania, 15224, United States

Location

MeSH Terms

Conditions

Overweight

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 9, 2011

First Posted

March 10, 2011

Study Start

July 1, 2004

Primary Completion

September 20, 2011

Study Completion

September 20, 2011

Last Updated

October 18, 2017

Record last verified: 2017-10

Locations